News from the FDA/CDC

Vaping-linked lung injury: 2,172 cases, 42 deaths


 

REPORTING FROM CDC

The Centers for Disease Control and Prevention has updated information about cases of e-cigarette, or vaping, product use–associated lung injury (EVALI): As of Nov. 12, there have been 2,172 cases reported from 49 states (all except Alaska), the District of Columbia, and two U.S. territories (Puerto Rico and U.S. Virgin Islands). Forty-two deaths have been confirmed in 24 states and the District of Columbia, the CDC reported.

E-cigarette ArminStautBerlin/Thinkstock

Laboratory test results of bronchoalveolar lavage fluid samples from 29 patients submitted to CDC from 10 states found vitamin E acetate in all of the samples. This is the first time a chemical of concern has been found in biologic samples from patients with EVALI. These findings provide direct evidence of vitamin E acetate at the primary site of injury within the lungs.

Tetrahydrocannabinol (THC) was identified in 82% of the samples and nicotine was identified in 62% of the samples. Testing continues for other chemicals including plant oils, petroleum distillates like mineral oil, medium-chain triglycerides oil, and terpenes, which are compounds commonly found in or added to THC products. None of these chemicals has been detected in the bronchoalveolar lavage fluid samples tested.

For more information and resources visit For the Public, For Healthcare Providers, and For State and Local Health Departments pages, as well as the CDC’s Publications and Resources page.

Recommended Reading

U.S. deaths from preventable causes occur more often in rural areas
MDedge Internal Medicine
Lung cancer on the decline, but still higher among men than women
MDedge Internal Medicine
CDC identifies probable culprit in vaping lung injuries
MDedge Internal Medicine
Getting high heightens stroke, arrhythmia risks
MDedge Internal Medicine
Lung cancer screening, early diagnosis still lower among blacks, Hispanics
MDedge Internal Medicine
Tiotropium/olodaterol improved lung function in steroid-free patients with COPD
MDedge Internal Medicine
Smokers with PE have higher rate of hospital readmission
MDedge Internal Medicine
Benefits of BGF triple fixed-dose therapy consistent in COPD patients without exacerbation history
MDedge Internal Medicine
Worse air quality linked to premature deaths
MDedge Internal Medicine
Teen survives double lung transplant after vaping injury
MDedge Internal Medicine